CG Oncology (CGON) IPO deck
CG Oncology is a privately held biopharmaceutical company that focuses on developing bladder-saving therapeutics for patients with bladder cancer.
CG Oncology is a privately held biopharmaceutical company that focuses on developing bladder-saving therapeutics for patients with bladder cancer.
%20IPO%20deck){kind=link}